BioCorRx Inc. (OTCMKTS:BICX) Files An 8-K Material Modification to Rights of Security Holders
Item 3.03 Material Modification to Rights of Security Holders.
On November 23, 2016, BioCorRx Inc., a Nevada corporation (the
Company), filed a certificate of designations, rights and
preferences (the Certificate of Designation)with the Secretaryof
State of the State of Nevada to which the Company set forth the
designation, powers, rights, privileges, preferences and
restrictions of the Series BPreferred Stock.
Among other things, the number of shares of Series B Preferred
Stock authorized was one hundred sixty thousand (160,000) shares,
with each one (1) share of the Series BPreferredStockentitling
its holder to two thousand (2,000) votes. The Series B Preferred
Stock is not entitled to dividends.
The foregoing description of the Series BPreferred Stock does not
purport to be complete and is subject to, and qualified in its
entirety by, the Certificate of Designation, a copyof which
isattached hereto as Exhibit 4.1 and incorporated herein by
reference.
Item 5.03 Amendments to Articles of Incorporation or
Bylaws; Change in Fiscal Year.
The applicable information set forth in Item 3.03 of this Current
Report on Form 8-K is incorporated by reference in this Item
5.03.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit 4.1 |
Certificate of Designation, filed November 23, 2016. |
|
2 |
About BioCorRx Inc. (OTCMKTS:BICX)
BioCorRx, Inc., formerly Fresh Start Private Management, Inc., is a holding company. The Company is an addiction healthcare solutions company operating in Santa Ana, California. The Company, through its subsidiary, Fresh Start Private, Inc., provides alcoholism and opioid treatment program. It offers a medication-assisted treatment program that combines non-addictive medication coupled with psycho-social counseling. It also distributes and licenses the BioCorRx Recovery Program for alcoholism and opioid addiction treatment. The BioCorRxO Recovery Program consists of over two parts, which include an implant, administered by a licensed physician, of a compounded formulation of the drug, Naltrexone (implanted under the skin) (the Implant), which reduces alcohol cravings over a period of time, and a structured, intensive one on one counseling program developed by it. It offers BioCorRx Recovery Program in over 10 locations, including California, Arizona, Atlanta, Illinois and others. BioCorRx Inc. (OTCMKTS:BICX) Recent Trading Information
BioCorRx Inc. (OTCMKTS:BICX) closed its last trading session up +0.0010 at 0.0350 with 10,500 shares trading hands.
